BAUSCH + LOMB CORP (BLCO) Stock Fundamental Analysis

NYSE:BLCO • CA0717051076

17.65 USD
-0.02 (-0.11%)
At close: Feb 19, 2026
17.65 USD
0 (0%)
After Hours: 2/19/2026, 8:04:00 PM
Fundamental Rating

2

Taking everything into account, BLCO scores 2 out of 10 in our fundamental rating. BLCO was compared to 185 industry peers in the Health Care Equipment & Supplies industry. While BLCO is still in line with the averages on profitability rating, there are concerns on its financial health. BLCO is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year BLCO was profitable.
  • BLCO had a positive operating cash flow in the past year.
  • In multiple years BLCO reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: BLCO reported negative operating cash flow in multiple years.
BLCO Yearly Net Income VS EBIT VS OCF VS FCFBLCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -2.21%, BLCO is in the better half of the industry, outperforming 69.73% of the companies in the same industry.
  • BLCO has a Return On Equity of -4.74%. This is in the better half of the industry: BLCO outperforms 70.27% of its industry peers.
  • The Return On Invested Capital of BLCO (0.77%) is better than 65.95% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLCO is significantly below the industry average of 8.75%.
Industry RankSector Rank
ROA -2.21%
ROE -4.74%
ROIC 0.77%
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.59%
ROIC(5y)1.92%
BLCO Yearly ROA, ROE, ROICBLCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

  • With a decent Operating Margin value of 2.33%, BLCO is doing good in the industry, outperforming 67.03% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BLCO has declined.
  • With a decent Gross Margin value of 59.45%, BLCO is doing good in the industry, outperforming 60.54% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
Industry RankSector Rank
OM 2.33%
PM (TTM) N/A
GM 59.45%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
BLCO Yearly Profit, Operating, Gross MarginsBLCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. Health

2.1 Basic Checks

  • BLCO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • BLCO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BLCO Yearly Shares OutstandingBLCO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
BLCO Yearly Total Debt VS Total AssetsBLCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • Based on the Altman-Z score of 0.89, we must say that BLCO is in the distress zone and has some risk of bankruptcy.
  • BLCO has a Altman-Z score (0.89) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.77 indicates that BLCO is somewhat dependend on debt financing.
  • BLCO's Debt to Equity ratio of 0.77 is on the low side compared to the rest of the industry. BLCO is outperformed by 69.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z 0.89
ROIC/WACC0.07
WACC10.35%
BLCO Yearly LT Debt VS Equity VS FCFBLCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.51 indicates that BLCO should not have too much problems paying its short term obligations.
  • BLCO has a Current ratio of 1.51. This is in the lower half of the industry: BLCO underperforms 74.05% of its industry peers.
  • BLCO has a Quick Ratio of 1.51. This is a bad value and indicates that BLCO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.98, BLCO is not doing good in the industry: 76.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 0.98
BLCO Yearly Current Assets VS Current LiabilitesBLCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2

3. Growth

3.1 Past

  • The earnings per share for BLCO have decreased strongly by -19.35% in the last year.
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.77%

3.2 Future

  • The Earnings Per Share is expected to grow by 32.47% on average over the next years. This is a very strong growth
  • BLCO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.83% yearly.
EPS Next Y60.98%
EPS Next 2Y47.19%
EPS Next 3Y40.75%
EPS Next 5Y32.47%
Revenue Next Year5.85%
Revenue Next 2Y5.67%
Revenue Next 3Y5%
Revenue Next 5Y3.83%

3.3 Evolution

BLCO Yearly Revenue VS EstimatesBLCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
BLCO Yearly EPS VS EstimatesBLCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 35.30, which means the current valuation is very expensive for BLCO.
  • 71.89% of the companies in the same industry are more expensive than BLCO, based on the Price/Earnings ratio.
  • BLCO is valuated rather expensively when we compare the Price/Earnings ratio to 27.09, which is the current average of the S&P500 Index.
  • BLCO is valuated rather expensively with a Price/Forward Earnings ratio of 21.93.
  • Based on the Price/Forward Earnings ratio, BLCO is valued a bit cheaper than 78.38% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of BLCO to the average of the S&P500 Index (27.98), we can say BLCO is valued slightly cheaper.
Industry RankSector Rank
PE 35.3
Fwd PE 21.93
BLCO Price Earnings VS Forward Price EarningsBLCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BLCO is valued a bit cheaper than 75.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.02
BLCO Per share dataBLCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • BLCO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BLCO's earnings are expected to grow with 40.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y47.19%
EPS Next 3Y40.75%

0

5. Dividend

5.1 Amount

  • BLCO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BAUSCH + LOMB CORP

NYSE:BLCO (2/19/2026, 8:04:00 PM)

After market: 17.65 0 (0%)

17.65

-0.02 (-0.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-18
Earnings (Next)N/A
Inst Owners11.05%
Inst Owner Change-2.22%
Ins Owners0.45%
Ins Owner Change0.1%
Market Cap6.25B
Revenue(TTM)N/A
Net Income(TTM)-305.00M
Analysts72.63
Price Target17.68 (0.17%)
Short Float %8.7%
Short Ratio10.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.13%
Min EPS beat(2)1.79%
Max EPS beat(2)8.47%
EPS beat(4)3
Avg EPS beat(4)-86.5%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)-37.66%
EPS beat(12)9
Avg EPS beat(12)-24.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.15%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.16%
Revenue beat(8)3
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.96%
PT rev (3m)14.6%
EPS NQ rev (1m)-3.3%
EPS NQ rev (3m)-5.77%
EPS NY rev (1m)0.21%
EPS NY rev (3m)0.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 35.3
Fwd PE 21.93
P/S 1.26
P/FCF N/A
P/OCF 37
P/B 0.97
P/tB N/A
EV/EBITDA 20.02
EPS(TTM)0.5
EY2.83%
EPS(NY)0.8
Fwd EY4.56%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)0.48
OCFY2.7%
SpS14.04
BVpS18.15
TBVpS-4.39
PEG (NY)0.58
PEG (5Y)N/A
Graham Number14.29
Profitability
Industry RankSector Rank
ROA -2.21%
ROE -4.74%
ROCE 0.97%
ROIC 0.77%
ROICexc 0.79%
ROICexgc 2.52%
OM 2.33%
PM (TTM) N/A
GM 59.45%
FCFM N/A
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.59%
ROIC(5y)1.92%
ROICexc(3y)1.64%
ROICexc(5y)1.97%
ROICexgc(3y)5.47%
ROICexgc(5y)6.76%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexgc growth 3Y-21.86%
ROICexgc growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Debt/EBITDA 9.05
Cap/Depr 85.28%
Cap/Sales 7.34%
Interest Coverage 250
Cash Conversion 31.07%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 0.98
Altman-Z 0.89
F-Score4
WACC10.35%
ROIC/WACC0.07
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
EPS Next Y60.98%
EPS Next 2Y47.19%
EPS Next 3Y40.75%
EPS Next 5Y32.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.77%
Revenue Next Year5.85%
Revenue Next 2Y5.67%
Revenue Next 3Y5%
Revenue Next 5Y3.83%
EBIT growth 1Y-38.95%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year46.23%
EBIT Next 3Y23.51%
EBIT Next 5Y15.82%
FCF growth 1Y-880%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.07%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%

BAUSCH + LOMB CORP / BLCO FAQ

What is the fundamental rating for BLCO stock?

ChartMill assigns a fundamental rating of 2 / 10 to BLCO.


What is the valuation status of BAUSCH + LOMB CORP (BLCO) stock?

ChartMill assigns a valuation rating of 4 / 10 to BAUSCH + LOMB CORP (BLCO). This can be considered as Fairly Valued.


Can you provide the profitability details for BAUSCH + LOMB CORP?

BAUSCH + LOMB CORP (BLCO) has a profitability rating of 4 / 10.


What is the financial health of BAUSCH + LOMB CORP (BLCO) stock?

The financial health rating of BAUSCH + LOMB CORP (BLCO) is 1 / 10.